Administration of pseudomonas end toxin conjugated to IL-13 (cintredekin besudotox) to individuals with glioma by CED was already tested under clinical tests.66 Furthermore, combining mAb therapy with other therapeutic modalities such as for example chemotherapy, radiotherapy, Tolcapone molecular-targeted therapy, or toxins has been proven to become more effective than antibody alone.67C69 Indeed, mix of the […]